43 related articles for article (PubMed ID: 7636196)
21. Antitumor x anti-CD3 bifunctional antibodies redirect T-cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases.
Penna C; Dean PA; Nelson H
Cancer Res; 1994 May; 54(10):2738-43. PubMed ID: 8168104
[TBL] [Abstract][Full Text] [Related]
22. Differential T cell hyporesponsiveness induced by in vivo administration of intact or F(ab')2 fragments of anti-CD3 monoclonal antibody. F(ab')2 fragments induce a selective T helper dysfunction.
Hirsch R; Archibald J; Gress RE
J Immunol; 1991 Oct; 147(7):2088-93. PubMed ID: 1833451
[TBL] [Abstract][Full Text] [Related]
23. Bifunctional antibody retargeting in vivo-activated T lymphocytes: simplifying clinical application.
Chapoval AI; Nelson H; Thibault C; Penna C; Dean P
J Hematother; 1995 Dec; 4(6):571-7. PubMed ID: 8846018
[TBL] [Abstract][Full Text] [Related]
24. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
Tutt A; Stevenson GT; Glennie MJ
J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of in vitro tumor-infiltrating lymphocyte cytotoxicity by heteroconjugated antibodies.
Reid I; Lundy J; Donohue JH
J Immunol; 1992 Apr; 148(8):2630-5. PubMed ID: 1532818
[TBL] [Abstract][Full Text] [Related]
26. Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer.
Liakou CI; Narayanan S; Ng Tang D; Logothetis CJ; Sharma P
Cancer Immun; 2007 Jun; 7():10. PubMed ID: 17591743
[TBL] [Abstract][Full Text] [Related]
27. Target cell induced T cell activation with bispecific antibodies: a new concept for tumor immunotherapy.
Wolf H; Freimann U; Jung G
Recent Results Cancer Res; 1994; 135():185-95. PubMed ID: 8047693
[No Abstract] [Full Text] [Related]
28. Toward the production of bispecific antibody fragments for clinical applications.
Carter P; Ridgway J; Zhu Z
J Hematother; 1995 Oct; 4(5):463-70. PubMed ID: 8581386
[TBL] [Abstract][Full Text] [Related]
29. Two-in-One antibodies with dual action Fabs.
Eigenbrot C; Fuh G
Curr Opin Chem Biol; 2013 Jun; 17(3):400-5. PubMed ID: 23683347
[TBL] [Abstract][Full Text] [Related]
30. Surfactant protein D/anti-Fc receptor bifunctional proteins as a tool to enhance host defence.
Breij EC; Batenburg JJ
Expert Opin Biol Ther; 2008 Apr; 8(4):409-19. PubMed ID: 18352846
[TBL] [Abstract][Full Text] [Related]
31. Anti-CD3 x anti-tumor F(ab')2 bifunctional antibody activates and retargets tumor-infiltrating lymphocytes.
Chapoval AI; Nelson H; Thibault C
J Immunol; 1995 Aug; 155(3):1296-303. PubMed ID: 7636196
[TBL] [Abstract][Full Text] [Related]
32. Strategies of lymphocyte activation for the adoptive immunotherapy of metastatic cancer: a review.
Strome SE; Krauss JC; Chang AE; Shu S
J Hematother; 1993; 2(1):63-73. PubMed ID: 7921967
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
